Formulation and Evaluation of Fixed-Dose Combination of Bilayer Gastroretentive Matrix Tablet Containing Atorvastatin as Fast-Release and Atenolol as Sustained-Release
Figure 6
In vitro release profile of atorvastatin from fast-release tablets containing atorvastatin-β-CD solvent evaporation product in 1 : 3 (drug/CD) molar ratio in comparison to atorvastatin powder performed in 0.1 M HCl at °C (mean ± S.E.; ).